{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-21-005860","form_type":"8-K","ticker":"XBIO","cik":"0001534525","company_name":"Xenetic Biosciences, Inc.","filed_at":"2021-11-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.947699+00:00","generated_at":"2026-06-28T06:32:52.131252+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Xenetic Biosciences enters $4M ATM equity offering with H.C. Wainwright","bullets":["Entered ATM Agreement with H.C. Wainwright as exclusive agent to sell up to $4M of common stock.","Shares sold at-the-market on Nasdaq; Wainwright receives 3% commission on gross proceeds.","Company has no obligation to sell any shares and may suspend or terminate the agreement.","Agreement effective November 19, 2021; filed as Exhibit 1.1 to the 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-21-005860","json":"https://secwatch.observer/filing/0001683168-21-005860.json","markdown":"https://secwatch.observer/filing/0001683168-21-005860.md","text":"https://secwatch.observer/filing/0001683168-21-005860.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534525/000168316821005860/0001683168-21-005860-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534525/000168316821005860/xenetic_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T06:32:52.131252+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}